Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Marketing Lebanese Hospitals

Other Linkages
Hospital accreditation cannot stand-alone and is not therefore "a panacea to cure all ills" within the hospital system. The OPCV Team has identified and documented other "Opportunities for Improvement" within the system, not the least of which are the following:
  • Hospital role delineation
  • A regional approach to planning of hospital services
  • The uniform collection of morbidity and mortality data through the establishment of a national health data bank
  • A tertiary education approach to medical records administration training
  • National health workforce planning in relation to key clinical groups such as physicians, nurses and pharmacists
  • A national approach to identified deficiencies in safety standards for hospital buildings, hospital waste management, and blood banking services
  • Strategic planning in relation to the medical technology and its dissemination throughout the country.
  • Creation of the national Accreditation structure, particularly the National Health Care Quality Council
 
The Accreditation Manual and Guidelines
The OPCV Team maintains that the entire Manual and Guidelines form the quality approach. No standards should be read in isolation, as there are interlocking standards and related services/departments across the system. However the following principles extracted from the Accreditation standards documentation (as opposed to Basic standards) illustrate some of the key areas, and code numbers have been indicated for easy cross-reference to the Accreditation manual.
 
 
Quality Systems
The Hospital Accreditation Manual and Guidelines place the accent clearly on quality by the inclusion of a Quality Systems chapter (QS).

The presence of a Quality Department that is established and funded is integral to a hospital and it must be understood that while quality activities and staffing do involve cost, quality improvement activities do save money over a period of time. Hospitals save funds through efficiencies, reduced re-admission rates, and more effective lengths of stay, improvement in hospital image, increased throughput of patients, and many other measures that accrue as part of the emphasis of a quality approach.

A hospital will increase its reputation by the development of quality hotel services, but only in conjunction with the quality systems it implements and through the development of quality plans. Within quality improvement plans (QS1), key functions should include:
  • Patient focused care. (QS)
  • Organizational improvements. (GB-14 )
  • Management of the hospital environment.(ES-2-5-8-14)
  • Management of the resources - human, infrastructural, financial and equipment.(ES-8-9-13)
  • Infection control management. (IC-7)
  • Collection and utilisation of data to improve the hospitals performance. (MR-19)
  •  Accurate documentation. (CN-2-10-4)
 
Patients Rights and Responsibilities. (QS-10-15-16)
A patient complaint process should be an integral part of the hospital administration systems, and should be contained in the general information given to patients on their admission to hospital .(QS-15)The patients right to make a complaint should be enshrined in hospital policies and procedures, and that includes feedback to the patient on what action, if any the hospital intends to take concerning the complaint. Patients complaints when considered objectively can lead to significant improvements in hospital processes and the quality of care, and therefore the image of the hospital. Patients should not be afraid to make complaints, particularly about the standards of treatment a hospital provides.

Part of the customer focus that is adopted by countries to improve the image of hospitals is to develop a questionnaire (QS-9-14) that is utilised by the patients and staff to ensure that the service the hospital is providing to the public is consistent and safe. The patients and staff provide information on any and every service within the hospital. The survey is sent on to the quality department for collation, evaluation and action. As indicated above the implementation of this standard, can significantly improve the process a hospital may utilise for excellent patient care.

A written patients charter (QS-15) is a convenient means of advising patients of their rights when entering hospital. The hospital will expect patients to make complaints through the designated procedures available. Patient's rights and responsibilities can be encapsulated within one patient's charter. The adoption of this process ensures that the customer, that is the patient, is included in the decisions that are made within the hospital through the patient feedback process. Quality standards have embedded within them such outcomes as ethics committees (QS-16 ) to consider ethical matters, confidentiality issues (QS-16-17-18 ), and the right to have a second medical opinion and the right to privacy for the patient and relatives (QS-17-18 ).
 
Human Resource Management. ( HR )
A comprehensive staff recruitment process (HR-3) should be the cornerstone of any human resources system and requires the recognition by the hospital that the staff are the hospitals greatest asset. The human resource component delivers the care to the patient and is an important part of any quality hospital system. Investment in continuing education (HR-8-9) ensures that staff are valued and worthy members of the hospital. Staff education improves the image of the hospital through efficient and safe care of the patient and improves the reputation for the hospital. Amongst other things, a high quality human resource department is integral to:
  • The human resource strategy of the hospital (HR-10-2)
  • Recruitment of all staff to the hospital. (HR-3)
  • In-service and ongoing education/training processes (QS-8-19-20)
  • Orientation program for all new hospital employees. (QS-8-HR-8)
  • Appropriate accounting systems that are accountable and transparent (HR-11-15-16)
  • Collection and analyses of utilisation statistics (sick leave, accident rates, staff qualifications, education and in-service programmes, staff appraisal). ( HR-10)
 
Medical Technology
There is a clear indication of a build up of medical technology in Lebanese hospitals despite under utilisation in many areas. A study by Jurjus showed that "the quantity and variety of health services are increasing almost everywhere in the country, generating new and additional costs". He concluded, "The major challenge is to develop a policy structure that can control medical technology acquisition and utilisation." There is an opportunity through hospital role definition and delineation, implementation of quality assurance and/or certificate of need legislation, for the MOPH to control the ad hoc acquisition of advanced medical technology, like many other countries have opted to do. There are standards scattered throughout the Accreditation manual that refer to appropriate levels of medical equipment (BM-3-8), properly maintained medical equipment (BM-4 ), staff familiarity with existing and new items of equipment (SC-13), and qualified staff in relation to sophisticated equipment use (SC-13-14)
 
Buildings, Procurement and Bio-medical.
Through standards development and implementation, quality of care to the patients and cost savings can be generated with improved management procedures regarding procurement, maintenance and utilization of building services plant and biomedical equipment.
  • Procurement principles and procedures. (BM-3)
  • Technical specifications. (BM-5)
  • Evaluation of bids and proposals for new equipment. (BM-3)
  • Equipment installation and acceptance testing. ( BU-1-2)
  • Updating and retention of technical skills of engineers sufficient to ensure trouble free operation and reliability of plant and biomedical equipment. (BM-2-7- SC-13)
  • The training of plant operators and users of biomedical equipment to maximise operational efficiency and mimimise the risk of clinical accidents. (BM-2-7-SC-13)
 
Safety
The responsibility by the hospital for a safe work environment is essential for the health of employees. It also has important follow on effects for patients- that is in the provision of a safe and secure hospital environment. Within the hospital situation this responsibility involves such area as radiation safety (RA-2-BU-2), infection control standards and education (IC-All Standards-IC-7-13-14-15), staff immunisation programs (OH-3), fire and hazardous materials and standards ( FF-4-5-7-BU-1), and hospital waste management programs ( WM-1-2-3-10-8), to name just a few.

Infrastructure development is essential for the safety of staff and patients and may be as simple as implanting smoke detectors within a hospital (BU-3). Education and training for staff in the emergency evacuation of patients is essential to preserve human life in crisis situations such fire, flood, and other disasters (FF-9-11-4).
 
Conclusion
This is a very brief excursion through the Accreditation Manual in an attempt to highlight quality standards and their link to a marketable hospital system. The paper places reliance on the fact that patients and health care staff, above all, want quality outcomes from health care and these outcomes are to be found in attention to all the standards, rather than merely emphasising the "hotel" standards of patient accommodation.
 
    2
    ...
ATC Name B/G Ingredients Dosage Form Price
R03AK06 PROPIONATE DE FLUTICASONE/ SALMETEROL ARROW G Salmeterol - 50mcg/dose, Fluticasone propionate - 500mcg/dose Inhalation powder 2,605,711 L.L
C05AX05 PROCTO GLYVENOL B Lidocaine - 40mg, Tribenoside - 400mg Suppository 399,121 L.L
C05AX05 PROCTO GLYVENOL B Lidocaine HCl - 2g/100g, Tribenoside - 5g/100g Cream 405,840 L.L
J07CA06 PENTAXIM B Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg Injectable dry powder+suspension 2,558,676 L.L
B05D PERITONEAL DIALYSIS SOLUTION WITH 4 1/4% DEXTROSE G Sodium lactate - 0.392g%, Calcium chloride, 2H2O - 0.0257g%, Magnesium chloride, 6H2O - 0.0153g%, Sodium chloride - 0.567g%, Dextrose, H2O - 4.25g% Injectable solution 498,744 L.L
B05D PERITONEAL DIALYSIS SOLUTION WITH 1 1/2% DEXTROSE G Sodium lactate - 0.392g%, Calcium chloride, 2H2O - 0.0257g%, Magnesium chloride, 6H2O - 0.0153g%, Sodium chloride - 0.567g%, Dextrose, H2O - 1.5g% Injectable solution 490,807 L.L
G04BX14 PRIXETIN 60 G Dapoxetine (hydrochloride) - 60mg Tablet, film coated 1,479,123 L.L
B05XA PEDITRACE B Sodium selenite 5H2O (anhydrous) - 6.66mcg/ml, Sodium fluoride - 126mcg/ml, Potassium iodide - 1.31mcg/ml, Zinc chloride - 521mcg/ml, Copper chloride - 53.7mcg/ml, Manganese chloride 4H2O - 3.6mcg/ml Injectable concentrated solution 4,749,139 L.L
L01BA04 PEMETREXED NEAPOLIS G Pemetrexed (disodium) - 500mg Injectable powder 41,289,202 L.L
A02BD08 PYLERA B Bismuth subcitrate potassium - 140mg, Tetracycline HCl - 125mg, Metronidazole - 125mg Capsule 6,156,142 L.L
C10BA03 PRAVAFEN B Pravastatin sodium - 40mg, Fenofibrate - 160mg Capsule, hard 1,264,556 L.L
N02BE51 PANADOL SINUS B Paracetamol - 500mg, Pseudoephedrine HCl - 30mg Caplet 228,453 L.L
N02BE51 PANADOL COLD & FLU DAY B Paracetamol - 500mg, Caffeine - 25mg, Phenylephrine HCl - 5mg Caplet 284,895 L.L
G01AA51 POLYGYNAX B Nystatin - 100,000IU, Polymixin B sulfate - 35,000IU, Neomycin sulfate - 35,000IU Capsule, vaginal 407,184 L.L
N02BE51 PANADOL COLD & FLU ALL IN ONE B Paracetamol - 250mg, Guaifenesin - 100mg, Phenylephrine HCl - 5mg Tablet, film coated 342,680 L.L
N02BE51 PANADOL COLD & FLU VAPOUR RELEASE + DECONGESTANT B Paracetamol - 600mg, Phenylephrine HCl - 10mg Powder for solution 524,099 L.L
N02BE51 PANADOL EXTRA WITH OPTIZORB B Paracetamol - 500mg, Caffeine - 65mg Tablet, film coated 524,099 L.L
A03AX12 PHLOROGLUCINOL/TRIMETHYLPHLOROGLUCINOL ARROW G Phloroglucinol - 40mg/4ml, Trimethylphloroglucinol - 0.04mg/4ml Injectable solution 940,690 L.L
N02BE51 PANADOL EXTRA WITH OPTIZORB B Paracetamol - 500mg, Caffeine - 65mg Tablet, film coated 252,642 L.L
N02BE51 PARACETAMOL/CAFEINE/CODEINE BIOGARAN G Paracetamol - 400mg, Caffeine - 50mg, Codeine - 20mg Capsule 548,288 L.L
N02BE51 PANADOL MIGRAINE B Paracetamol - 250mg, Acetylsalicylic acid - 250mg, Caffeine - 65mg Caplet 604,729 L.L
M03BB53 PARAXONE-JPI G Paracetamol - 300mg, Chlorzoxazone - 250mg Capsule 334,617 L.L
N02BE51 PANADOL COLD AND FLU B Paracetamol - 500mg, Pseudoephedrine HCl - 30mg, Chlorpheniramine maleate - 2mg Tablet 278,175 L.L
N02BE71 PYRETHAL G Paracetamol - 200mg, Phenobarbital - 20mg Suppository 147,183 L.L
N02BG09 PENTHROX INHALER B Methoxyflurane - Inhalation 21,080,096 L.L
B05BA10 PERIOLIMEL N4E B Olive oil + Soja oil - 45.00g, Alanine - 5.50g, Arginine - 3.72g, Aspartic Acid - 1.10g, Glutamic Acid - 1.90g, Glycine - 2.63g, Histidine - 2.26g, Isoleucine - 1.90g, Leucine - 2.63g, Lysine - 2.99g, Methionine - 1.90g, Phenylalanine - 2.63g, Proline - 2.26g, Serine - 1.50g, Threonine - 1.90g, Tryptophan - 0.64g, Tyrosine - 0.10g, Valine - 2.43g, Sodium acetate, 3H2O - 1.73g, Sodium glycerophosphate, H2O - 2.87g, Potassium chloride - 1.79g, Magnesium chloride, 6H2O - 0.67g, Calcium chloride 2H2O - 0.44g, Glucose monohydrate - 123.75g Injectable emulsion 5,288,020 L.L
A03CA02 PRIMAX G Clidinium bromide - 2.5mg, Chlordiazepoxide - 5mg Tablet 222,694 L.L
C09DB01 POVAM G Amlodipine (besylate) - 5mg, Valsartan - 160mg Tablet, film coated 857,372 L.L
A03DB04 PANADOL WOMAN B Paracetamol - 500mg, Hyoscine butylbromide - 10mg Tablet, coated 436,749 L.L
C07BB07 PRESCOR 5 PLUS G Bisoprolol - 5mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 678,321 L.L
    2
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025